Presentation is loading. Please wait.

Presentation is loading. Please wait.

Cardiovascular Market Trends

Similar presentations


Presentation on theme: "Cardiovascular Market Trends"— Presentation transcript:

1 Cardiovascular Market Trends
Cardiovascular Roundtable & Service Line Strategy Advisor Cardiovascular Market Trends Ready to Use Presentation Slides Prepared April 2016

2 Growth Outlook Payment Updates Reform & Payment Transformation
Service Line Strategy Clinical Innovation Additional Resources

3 Enduring Pressures Escalating New Pressures Emerging
Market Forces Impacting CV Strategy Enduring Pressures Escalating New Pressures Emerging Decelerating Reimbursement Growth Increase in Risk-Based Contracts, P4P1 Shifting Demand to Less Profitable Services Empowered Patient Consumers Heightened Utilization Scrutiny Pay-for-performance. Source: Advisory Board Research and Analysis.

4 Cardiovascular Disease Projected to Grow
CV Programs Focusing Investments to Meet Increasing Disease Burden Projected HF, CHD Prevalence in the U.S. , Percentage of Total Population Projected AF Prevalence in the U.S. , In Millions Source: Colilla, S., Crow, A., Petkun, W., Singer, D. E., Simon, T., Liu, X. (2013). Estimates of Current and Future Incidence and Prevalence of Atrial Fibrillation in the U.S. Adult Population. American Journal of Cardiology. Oct 2013; 112(8): Heidenreich, P. A., et al. Forecasting the Future of Cardiovascular Disease in the United States: A Policy Statement from the American Heart Association. Circulation. Jan : Advisory Board research and analysis.

5 A New CV Growth Paradigm
Forecasting Growth in CV Outpatient, Medical Services CV Volume Growth Projections by Sub-Service Line A Dual Mandate All-Payer, Build and expand ambulatory, medical services Maintain and defend declining procedural volumes Outpatient Cardiac Cath Inpatient Arterial Disease Inpatient Other Vascular Inpatient Cardiac EP Inpatient Medical Cardiology Inpatient Cardiac Cath Note: Access the Cardiovascular Roundtable’s inpatient and outpatient market estimators for five-year forecasts specific to your market. Source: The Advisory Board’s Inpatient and Outpatient Market Estimator tools; Advisory Board Research and Analysis.

6 Inducements and Barriers
Assessing Drivers of CV Subspecialty Growth Five Year Growth Trajectories Inducements and Barriers Demographic Improved ambulatory disease management reduces HOPD volumes Technology advancements expand minimally invasive treatment options Poor patient compliance with lifestyle and prevention options Increasing prevalence of obesity, high cholesterol, diabetes and hypertension Aging population RAC audits discourage inappropriate utilization Emphasis on readmission prevention Clinical Market Focus on population health shifts demand toward early diagnosis and intervention Percutaneous coronary intervention. Coronary artery bypass grafting. Cardiac resynchronization therapy with defibrillation. Peripheral vascular intervention. Transcatheter aortic valve replacement. Source: The Advisory Board’s Inpatient and Outpatient Market Estimator tools; Advisory Board Research and Analysis.

7 -5% 51% 11% PCI Declining as Providers Proliferate
Competition Increasing for Cath Volumes Number of PCI1 Programs Nationally PCI Volume and Provider Trends Decrease in PCI volumes nationally -5% Portion of PCI hospitals experiencing contracting demand for PCI 51% Portion of PCI hospitals performing <25 inpatient Medicare PCI procedures in 2014 11% Percutaneous coronary intervention. Source: Advisory Board Research and Analysis.

8 Decrease in total number of CABG admissions between 2008 and 2012
CABG Reaching a Tipping Point For First Time, More Open Heart Surgery Programs Closing Than Opening Low-Volume Programs Feeling the Pressure 18,000 CABG Volume Change by Program Volume1 Decrease in total number of CABG admissions between 2008 and 2012 20% with Lowest Volume CV Forced to Make Difficult Decisions Leading Indicators for Programs Evaluating Consolidation Declining program, physician volumes Low performance on outcomes measures Inability to secure coverage Strong, high-quality competitor activity Conflicting system priorities Significant market activity in risk-based contracts Number of U.S. Open Heart Surgery Programs 16 programs closed Based on 2014 volume. Note: For additional analyses on open heart program closure and impact, please access the Roundtable blog post “What Happens When Hospitals Shutter Open Heart Programs.” Source: Advisory Board Research and Analysis.

9 Payment Updates Growth Outlook Reform & Payment Transformation
Service Line Strategy Clinical Innovation Additional Resources

10 CV Inpatient Reimbursement Staying Relatively Flat
Mixed Bag of Payment Changes with Final 2016 Rule Inpatient Cardiac Payment Changes Payment Updates for Select Services Final FY 2016 Versus Final FY 2015 Final FY 2016 Versus Final FY 2015 CV Service Payment Change DES 2.4% Peripheral Vascular Intervention/Bypass 1.6% CAS 1.5% CABG 1.1% Bare Metal Stent/Other PCI 1.0% Arrhythmia 0.9% ICD 0.8% Pacemaker 0.6% Amputation 0.5% CEA (0.3%) AMI (0.6%) Heart Failure (1.0%) Valve TAVR (3.2%) Cardiac Cath1 Cardiac Surgery Medical Cardiology EP1 Cardiac Overall Inpatient Vascular Payment Changes Final FY 2016 Versus Final FY 2015 Amputation Arterial Disease Other Vascular Venous Disease Vascular Overall Change in payment is primarily a result of ablation codes moving from cath to EP sub-service line. Source: FY 2016 Inpatient Prospective Payment System Final Rule, CMS; Advisory Board Research and Analysis. .

11 For First Time, Outpatient Payments Will Fall
Payment Decrease Reflective of Expected Efficiency Gains Hospital Outpatient Payment to Decline APC Payment Rates for Select CV Services2 Final CY Final CY 2016 APC Description 2016 Payment 5188 Diagnostic Cardiac Cath $2,549 51911 Level 1 Endovascular Proc. $4,592 51931 Level 3 Endovascular Proc. $14,612 52121 Level 2 Electrophysiologic Proc. $4,698 52131 Level 3 Electrophysiologic Proc. $15,561 52221 Level 2 Pacemaker & Similar Proc. $6,697 52311 Level 1 ICD and Similar Proc. $21,930 5561 Level 1 Echo Without Contrast $454 5181 Level 1 Vascular Proc. $863 5182 Level 2 Vascular Proc. $2,247 5183 Level 3 Vascular Proc. $3,795 5592 Level 2 Nuclear Medicine $441 5593 Level 3 Nuclear Medicine $1,108 2016 2013 2014 2015 Significant Restructuring of Nine APC Clinical Families 1 Vascular Procedures 5 Imaging Services 2 Diagnostic Tests 6 Ortho Procedures 3 GI Procedures 7 Skin Procedures 4 Excision/Biopsy and Incision and Drainage Procedures 8 Urology 9 Air Endoscopy Comprehensive-APCs. Complete CV outpatient payment updates table available on the online Resource Page. Source: CY 2016 Hospital Outpatient Prospective Payment System Final Rule, CMS; Advisory Board Research and Analysis.

12 Interventional Radiology
Physician Payment Updates Holding Steady SGR Replacement Locks in Slow Payment Growth Going Forward Estimated Impact on Select Specialties Payment Changes for Select CV Services MPFS Final CY 2016 MPFS Final CY 2016 Versus CY 2015 CPT Procedure Description Payment Change 93458 Left heart cath (26) 0.0% 78452 Heart muscle image spect, mult (TC) 33208 Insertion of heart pacemaker 33430 Replacement of mitral valve 33533 CABG, arterial, single (0.1%) 93650 Ablate heart dysrhythm focus 93306 Transthoracic echo with spectral and color flow Doppler (TC) 93015 Cardiovascular stress test (1.2%) Cardiology Cardiac Surgery Thoracic Surgery Interventional Radiology Annual Physician Payment Updates Established by MACRA1 0.75% APM2 Track MIPS3 Track 2026 Onward Medicare Access and CHIP Reauthorization Act of 2015; the bill repealing and replacing the SGR. Advanced alternative payment models. Merit-Based Incentive Payment System. Source: CY 2016 Medicare Physician Fee Schedule Final Rule, CMS; H.R.2: Medicare Access and CHIP Reauthorization Act of 2015; Advisory Board Research and Analysis.

13 A Dramatic Shift to Risk for Physician Payments
SGR Repeal and Replacement Imposes Mandatory Value-Based Models Two Physician Payment Tracks Established by MACRA, Beginning 2019 Key Takeaways for CV Leaders 1 Merit-Based Incentive Payment System (MIPS) Consolidates existing P4P programs into one program with a single payment Score based on quality, resource use, clinical improvement, and EHR use Payment adjustments hit -9% to +27% at risk for 2022 and onward More Risk Is on the Table MACRA places more payment at risk than hospital P4P programs Aligns Physician and Hospital Incentives New payment models encourage strong partnership to succeed on similar value-based goals 2 Alternative Payment Models (APMs) Requires physicians have significant share of revenue in contracts with two-sided risk Provides financial incentives (5% participation bonus ), exemption from MIPS APMs yet to be defined by CMS; must involve downside risk, quality measurement But Still a Few Years to Go Until MACRA models take effect in 2019, PQRS and VBPM programs will continue to roll out Note: For additional details, please see the Advisory Board’s webinar on the SGR Repeal. Source: H.R.2: Medicare Access and CHIP Reauthorization Act of 2015; Advisory Board research and analysis.

14 140% Increasing Support for Site-Neutral Payments
Unbalanced Volume and Payment Growth by Setting Captures Attention Higher Reimbursement at HOPD1 Versus Freestanding Physician Office Historic Support for Site-Neutral Payments MedPAC Urges Site-Neutral Payments First recommended in June 2013 Reiterated earlier recommendations in March 2014 and August 2014 140% Medicare payment differential for a level II echo performed in HOPD vs. physician office setting CMS Begins Collecting Site-of-Service Data Finalized in CY 2015 HOPPS rule Hospitals billing under HOPPS will report modifier, providers will use new POS3 codes on claims Reporting voluntary in 2015, mandatory 2016 Disproportionate HOPD Volume Growth Echo2 Volume Change by Setting, Included in Bipartisan Budget Act of 2015 Physician Office Signed by President Obama on Nov. 2 Prohibits newly opened or acquired off- campus HOPDs from billing on HOPPS beginning January 1, 2017 Hospital outpatient department. CPT Place of service. Source: MedPAC, CY 2015 Hospital Outpatient Prospective Payment System Final Rule, CMS; H.R Bipartisan Budget Act of 2015; Advisory Board research and analysis.

15 CV Services Vulnerable to Short-Stay Scrutiny
Two-Midnight Rule Focuses Attention on Appropriate Site of Service Service Lines with Highest Proportion of Cases At-Risk for Short Stay Scrutiny Length of Stay for Common CV Cases Medicare, FY 2014 Cardiac Services Vascular Services Medicare FFS Short Stays, FY 2014 CV Condition 1-Day LOS 1 or 2-Day LOS Arrhythmia 23% 48% Heart Failure 9% 26% Hypertension 30% 59% ICD 15% PCI 20% 47% PPM1 12% 33% PVI2 14% 29% Chest pain 75% Permanent pacemaker. Peripheral vascular intervention, transcatheter or bypass. Note: Access the Two-Midnight Rule Impact Assessment tool for an institution-specific assessment of short-stay services at-risk for payment denial. Source: Medicare Provider Analysis and Review File, CMS, February 18, 2015; Advisory Board Research and Analysis.

16 Reform & Payment Transformation
Growth Outlook Payment Updates Reform & Payment Transformation Service Line Strategy Clinical Innovation Additional Resources

17 Payment Reforms Target CV Services
Bundled Payment Initiatives Accountable Care Organizations 17 of the 48 conditions in BPCI1 are CV-specific 97% of the costliest 20% of Medicare beneficiaries have at least one CV diagnosis3 93% of BPCI participants in Models 2, 3, and 4 are bundling for at least one CV condition2 ACOs target cost-reduction efforts toward these costliest populations Pay-for-Performance Programs CV-Specific Alternative Payment Model 50% of the six conditions included in the Hospital Readmissions Reduction Program for FY 2017 are CV-related CMS launches Million Hearts®: CV Disease Risk Reduction Model in January 2016 New cost per episode of care and excess days utilization measures added to IQR4 for HF, AMI, signaling potential future inclusion in VBP5 First pilot payment innovation model tying payment to CV risk reduction, incentivizing primary prevention Bundled Payment for Care Improvement Initiative; 2) As of July 15, 2015; 3) Medicare, 2011. 4) Hospital Inpatient Quality Reporting program; 5) Value-Based Purchasing program. Source: CMS, “Bundled Payment for Care Improvement Initiative,” CMS, Advisory Board Research and Analysis..

18 Scope of CV Accountability Expanding
New Metrics, P4P Up the Stakes for Long-Term Care Management Key Drivers Expanding CV Accountability for Cross-Continuum Outcomes Hospital Readmissions Reduction Program Excess Days in Acute Care Metrics for HF, AMI Alternative Payment Models Adding CABG in FY2017 Maximum penalty now 3% of all inpatient Medicare revenue Added to IQR for 2018 Measures all acute use 30- days post-discharge (e.g., ED, observation, inpatient) BPCI including episodes of 30, 60, 90 days ACOs further expand target care episode Expands conditions Expands utilization scrutinized Expands timeframe Source: Advisory Board Research and Analysis.

19 Ready or Not…CABG Added to HRRP for FY 2017
Breaking Down the New 30-Day CABG Readmissions Metric CABG Added to Current HRRP Conditions Claims-based, risk-adjusted metric All-cause, unplanned readmissions Hospital penalized for excess CABG readmissions even if it performs well for other conditions Targeting the Admitting Hospital Penalizes index admitting hospital vs. discharging hospital This is different from the other HRRP measures (e.g., HF, AMI), which target discharging hospital Hospitals Are Already Under the Microscope Penalties start with FY payment (October 2016) Will likely be based on performance from July 1, 2012 to June 30, 20151 Possibly Excluding the Most Vulnerable Procedure Criteria: Isolated CABG only; does not include CABG + valve or valve surgeries Hospital Criteria: Programs with >25 CABGs over three-year measurement period (excluding Medicare Advantage) Will not be finalized until FY2017 IPPS ruling, yet this timeframe is consistent with past years. Source: Suter SG, et al., “Hospital-Level 30-Day All-Cause Unplanned Readmission Following CABG: Updated Measure Methodology Report,” Quality-Initiatives-Patient-Assessment-Instruments/HospitalQualityInits/Measure-Methodology.html; Advisory Board Research and Analysis.

20 93% CMS Aiming to Expand Bundled Payment Initiatives
Placing Even Greater Emphasis on Total Cost Controls Providers Involved in BPCI Phase II Inpatient Ruling Makes Clear CMS’ Intent to Continue Bundling in Future As of August 2015 CMS is committed to testing new payment and service delivery models… The primary goal for this solicitation of public comments is to receive information about a potential expansion of the BPCI initiative. CMS FY 2016 IPPS Proposed Rule Majority of BPCI Programs Involve CV Bundling Areas CMS Requested Input Regarding BPCI Breadth and scope of expansion Episode definitions Setting bundled payment amounts Administering bundled payments Quality measurement, payment for value Transitioning from FFS to bundled payments Percentage of BPCI participants in models 2, 3, 4 that are bundling for at least one CV condition1 93% As of July 15, 2015. Source: CMS, “Bundled Payment for Care Improvement Initiative,” CMS, FY 2016 Inpatient Prospective Payment System Final Rule, CMS; Advisory Board Research and Analysis.

21 1 2 3 Are CV Services Next for Mandatory Bundling? 532% 800K 230K
CMS’ Criteria Used to Select Joints Applicable to Many CV Services Three Criteria Used to Select Joint Replacement Bundle 1 2 3 Significant Cost Variation High Prevalence In Medicare Beneficiaries Services Bundled in BPCI Program 532% 800K Most Common Bundles Among BPCI Participants Bundling for CV Cost variation of PCIs in one sample market Discharges with heart failure as primary diagnosis, 2014 Rank CV Condition/Procedure 1 Congestive heart failure 2 Acute myocardial infarction 3 Cardiac arrhythmia 4 Pacemaker 5 Coronary artery bypass graft 230K CABG procedures in 2014 Source: Blue Cross Blue Shield, “A Study of Cost Variation for PCI in the US,” July 16, 2015; CMS, “Bundled Payment for Care Improvement Initiative,” CMS, Advisory Board Research and Analysis.

22 Impact of Care Delivery Transformation on CV
Leap in Cardiologists Reporting Participation in ACOs ! Possible Impact on CV Programs Market Scenarios 1 PCP-led ACO develops ACO limits access to high-end CV procedures PCPs refer to CV later in disease progression PCPs take a greater role in ongoing care management of CV patients Hospitals deemphasize investment in high-end acute care to focus on ambulatory, population health CV program locked out of referral network 2 Competitor hospital forms an ACO 3 Your institution becomes part of an ACO Self-Reported Cardiologists Participating in ACOs Source: and 2013 Medscape Physician Compensation Reports: Advisory Board Research and Analysis.

23 Year 1 Years 2+ “Million Hearts” Nudging CV into Prevention
CMS Introduces First Pilot Specifically for CV Primary Prevention Screen Medicare beneficiaries who have not yet had heart attack or stroke for ten year risk Million Hearts®: CV Disease Risk Reduction Initiative Year 1 CMMI1 initiative announced May 2015 Will run five years, beginning January 2016; CMMI hopes to enroll 720 practices Targets for risk management are panel-wide, not per-patient, emphasizing development of holistic health management strategies Only includes patients who have not yet had a heart attack or stroke Ultimate goal is to prevent 1 million heart attacks and strokes across next five years through clinical- and community-based strategies Identify highest-risk patients Manage highest-risk patients Years 2+ Submit data biannually to CMS CMS provides payment for medical management Center for Medicare and Medicaid Innovation. Source: “Million Hearts,” CMS, Advisory Board Research and Analysis.

24 Service Line Strategy Growth Outlook Payment Updates
Reform & Payment Transformation Service Line Strategy Clinical Innovation Additional Resources

25 Snapshot of the CV Service Line Today
Current Programs Range in Sophistication Spectrum of Features Characterizing CV Service Lines Percentage of Service Line Respondents with Each Feature Foundational Progressive Dedicated administrator (85%) Dedicated strategic plan (77%) Joint physician/business administrator leadership (71%) Standardized clinical protocols1 (65%) Standardized operational policies, procedures (61%) Majority of CV specialists contractually affiliated2 (60%) Managed against a defined dashboard (60%) Infrastructure for multidisciplinary care, treatment planning (55%) Defined governance structure with purview over strategy, operations (54%) Dedicated budget (52%) Shared performance metrics across all divisions (52%) Integrated reporting structure for inpatient and outpatient services (50%) Reporting structure organized around specific disease states (38%) Collocated services (38%) Unified identity across sites3 (36%) Single, integrated profit/loss statement (29%) E.g., implementation of evidence-based practice. E.g., via employment or comanagement. E.g., recognized by physicians and patients as one cohesive collection of services. Source: 2014 Cardiovascular Roundtable CV Organizational and Leadership Structure Survey; Advisory Board Research and Analysis.

26 New Service Line Structures Align with Strategic Aims
Adapting Org Structure in Unique Ways in Response to Market Dynamics Multiple Priorities for Service Line Reorg1 Leading to New Service Line Models Rank Priority 1 Enabling greater market capture 2 Enabling more cost-effective care delivery 3 Embedding physicians into leadership 4 Improving multidisciplinary care delivery 5 Developing a disease-based model 6 Integrating acquired/affiliated physician offices 7 Incorporating multiple hospitals into a system-wide service line 8 Merging cardiac and vascular services 9 Integrating ambulatory, inpatient services 10 Supporting adoption of value-based contracts Integrating ambulatory services under service line umbrella Incorporating physician practices into reporting structure Organizing services around disease states across service line Developing a system-wide CV service line Grouping services by care redesign focus Of respondents who indicated they have or plan to reorganize; respondents were asked to rank top three priorities for their service line reorganization. Rank determined by a weighted calculation: items ranked first are valued higher than the following ranks; the score is the sum of all weighted rank counts. Source: 2014 Cardiovascular Roundtable CV Organizational and Leadership Structure Survey; Advisory Board Research and Analysis.

27 How Your Peers are Organizing their Service Line
Reporting Relationship to CV Service Line for Hospital CV Services and Units Percentage of Respondents CV Service Line Noninvasive CV Diagnostics Cath Lab EP Lab Cardiac/Vascular Rehab Cardiac Surgery Hybrid OR Direct 85% Indirect 11% External 4% Direct 84% Indirect 12% External 4% Direct 83% Indirect 13% External 4% Direct 71% Indirect 14% External 14% Direct 52% Indirect 38% External 10% Direct 43% Indirect 32% External 25% Vascular Surgery Inpatient Cardiac Units Thoracic Surgery CV Nursing Interventional Radiology Direct 35% Indirect 33% External 32% Direct 27% Indirect 37% External 37% Direct 29% Indirect 35% External 36% Direct 29% Indirect 32% External 39% Direct 16% Indirect 16% External 68% Note: Direct = directly reports to CV service line; indirect = indirectly reports to CV service line; external = does not report to CV service line. Source: 2014 Cardiovascular Roundtable CV Organizational and Leadership Structure Survey; Advisory Board Research and Analysis.

28 CV Service Line Purview Expanding Definition of Core Services
More of the Continuum Reporting to CV Service Line Purview Often Extending Outside the Acute Arena Reporting Relationship to CV Service Line for Key Ambulatory Services Percentage of Respondents CV Service Line Purview Acute CV Services Outpatient CV Clinics Cardiac Wellness & Prevention CV Physician Offices Direct 65% Indirect 16% External 19% Direct 61% Indirect 18% External 21% Direct 39% Indirect 19% External 42% Expanding Definition of Core Services Source: 2014 Cardiovascular Roundtable CV Organizational and Leadership Structure Survey; Advisory Board Research and Analysis.

29 Traditional Responsibilities Emerging Strategic Responsibilities
Service Line Administrator Role in Transition Expected to Take on Expanded Purview, More Strategic Focus Market Forces Transforming CV Administrator Role Yielding New Challenges Traditional Responsibilities Emerging Strategic Responsibilities Skillset not aligned with new role Managing inpatient setting New business development, volume growth CV operations (e.g., throughput, personnel management) Aligning full CV continuum Total cost management Capturing market share Aligning with physicians Defining CV’s care redesign strategy Building partnerships with new entities (e.g., ACOs) Strategy more complex due to reform, new care models Unfamiliarity with new sites under CV purview (e.g., ambulatory) “I used to be a program builder—I started the cath lab, the EP lab, figured out what equipment to buy. Now, my role is to understand where to direct patients in the system, develop risk-based contracts, contract with physicians, etc.” Workload becomes unmanageable as new responsibilities added VP of CV Services, System in the East Source: Advisory Board Research and Analysis.

30 11% 35% A Steady Trend of CV Physician-Hospital Alignment
ACC1 Outlines Recent Trends in Employment Percentage of Cardiologists Employed by Hospitals, 2007 vs. 2012 2007 2012 11% 35% Continuing to Engage in Formal Affiliation Roundtable Members Using Each Alignment Strategy, by CV Specialty, 20142 American College of Cardiology. Hospitals instructed to select “yes” response if any CV specialist is employed or under co-management. Source: 2012 American College of Cardiology Physician Practice Census, Cardiovascular Roundtable CV Physician Alignment Strategy Survey; Advisory Board Research and Analysis.

31 Prevalence of CV Service Line Leadership Models
Programs Embracing Shared Leadership at the Top Dyad, Triad Models Common for Managing CV Service Lines Prevalence of CV Service Line Leadership Models Percentage of Respondents, 2014 n=97 Dyad (e.g., business administrator and physician leader) Other Business Administrator Only Triad (e.g., business administrator, two physician leaders from different CV specialties) Source: 2014 Cardiovascular Roundtable CV Organizational and Leadership Structure Survey; Advisory Board Research and Analysis.

32 Key Responsibilities for Administrative and Physician Leaders
Dyad Leaders Sharing Management Responsibilities Joint Leadership Capitalizes on Each Individual’s Expertise Key Responsibilities for Administrative and Physician Leaders Administrator Dyad Shared Physician Dyad Clinical operations Budget management Supply chain management Coordination with related hospital functions (e.g., nursing, finance) Labor relations Strategic planning Performance scorecard development, monitoring Marketing, referral strategy CV care redesign strategy Cross-continuum care coordination New clinical program development, partnerships Quality improvement Protocol development, evidence-based practice Resource utilization management, cost control Advocating service line initiatives to physician peers Medical staff relations Reviewing technology, clinical program requests Source: Biga C et al., “Developing and Managing a Successful CV Service Line,” American College of Cardiology, 2012; Advisory Board Research and Analysis.

33 Elapsed Time Since Merger
CV an Afterthought of Macro-Level Market Strategy Network Realignment of High-End CV Services Often Occurring Later Common Action Items Following Health System Merger or Acquisition Primary Options for More ‘Rationale’ Deployment of CV Services Consolidate senior corporate management Consolidate Services Reduce redundancy in services and sites to eliminate excess capacity, streamline operations Immediate Eliminate duplicative contracts, renegotiate with suppliers Reallocate Services Distribute services in a more principled manner that aligns with market demand, supply Elapsed Time Since Merger Consolidate administrative departments (e.g., IT, finance) Substitute Services Downsize or consolidate one service while expanding another, allowing for more specialization Consolidate ancillary services (e.g., radiology, lab, pharmacy) Reallocate, consolidate CV services Expand Services Grow service offerings in markets with identified portfolio gaps Long Term (3-5 Years) Source: Advisory Board Research and Analysis.

34 Purchasers’ Geographic Preferences for CV Services
Feeling Obligated to Offer a Full Suite of CV Services Yet Difficult to Balance Access Demands for Core, High-End Services Purchasers’ Geographic Preferences for CV Services Balancing Demand for Convenience with Willingness to Travel Neighborhood Conveniences Local Offerings Regional/National Destinations Consolidated, collocated CV outpatient centers Virtual visits, remote monitoring Disease management, care navigation Disease-specific clinics (e.g., HF, valve, a-fib) Same-day, urgent clinics Transplants VADs3 Robotic surgery TAVR4 Potential Differentiators Clinic consultations, device checks Routine cardiac, vascular diagnostics Labs and medication management CV non-invasive imaging Coronary CTA1 Diagnostic caths PCI PVI2 ICD, pacemaker insertions Cardiac rehab Open heart surgery Surgical aortic, mitral valve repair/replacement EP ablation Core Services Computed tomography angiography. Peripheral vascular interventions. Ventricular assist device. Transcatheter aortic valve replacement. Source: Advisory Board Research and Analysis.

35 Referring Physician Preferences Steadily Evolving
High-Value Specialist Partners Succeed in Changing Market Source of CV Patient Referral Still Physician Referring Physician Preferences for Specialist Partners Respondents to Specialist Consumer Choice Survey1 Can assure quality, patient-centered care n=12,610 Low cost, ensuring only appropriate use Gives timely feedback on consults, referral requests Provides easy-to-use guidelines on when and how to refer Physician Referral (PCP or Specialist) Self- Referral Guarantees to return patient once appropriate Provides support for ongoing care Drivers of Shifting Preferences Alternative payment models (e.g., ACOs) place PCPs at risk for total cost New physician reimbursement mechanisms (e.g., MIPS) place PCPs accountable for cross-continuum coordination with specialists Online survey of 12,610 patients who had specialist appointments in the past 12 months. Source: 2015 Marketing Innovation Center Specialist Consumer Choice Survey; Advisory Board Research and Analysis.

36 Market Characteristic
What Does the Market Want From You? Defining a Growth Strategy that Meets Your Unique Market Needs Market Characteristic Growth Approach Highly competitive CV market Prioritize access, designing patient-centered services to keep patients within network Strengthen partnerships with PCPs, ACO, to secure and enhance referral streams Significant ACO presence Pervasive payer steerage and/or patients with HDHPs Ensure care provided in lowest-cost setting; consider moving diagnostics to physician clinics to lower co-payment Rapid transition to population health models in market Develop CV wellness, prevention clinics affiliated with the CV service line Strong retail clinic presence Double-down on convenience and access; enhance partnerships with clinic’s affiliated PCPs to capture downstream referrals Presence of large, accountable (e.g., self-insured) employers Propose risk-based, direct-to-employer contracts for CV to capture employee volume Source: Advisory Board Research and Analysis.

37 Clinical Innovation Growth Outlook Payment Updates
Reform & Payment Transformation Service Line Strategy Clinical Innovation Additional Resources

38 Interventional Cardiology
Technology Pipeline for Cardiovascular Services Future-Looking Technologies and Procedures in CV Cardiac Surgery Interventional Cardiology EP/Heart Failure Vascular Move Toward More Advanced Heart Assist Devices Innovative Therapies Show Promise for Intervention Remote Monitoring Aids Heart Failure Management High-End Endovascular Techs Expand Treatment Third Generation VADs1 Next-gen VADs aim to be smaller and fully implantable, eliminating the driveline VADs also to be magnetically levitated, eliminating wear and tear on the device and allowing longer device life in patients Interventional Valve Repair/Replacement Transcatheter aortic and mitral valve interventions fill treatment gap for patients at surgical risk Left Atrial Appendage Closure Catheter-delivered device seals off left atrial appendage, providing an alternative therapy for mitigating stroke risk in AF2 patients Implantable Pulmonary Artery Sensors Permanent implantable sensors measure pulmonary artery pressure to monitor heart failure progression Sensor requires no batteries, leads, or replaceable parts; sends data to electronic system that can be accessed daily Fenestrated Stent Grafts Grafts with holes align with intended branch vessels, permitting incorporation of the visceral and renal arteries into the endovascular repair Advancements open up endovascular therapy to patients with short or angulated necks Ventricular assist devices. Atrial fibrillation. Note: For additional information on progressive CV technologies, access the Cardiovascular Clinical Technology Compendium. Source: Advisory Board Research and Analysis.

39 TAVR1 Market Expanding Despite Barriers to Entry
Infrastructure Needs, Financial Challenges Not Limiting Investment Number of TAVR Sites in the U.S. MEDPAR data, Estimated TAVR Device and Procedure Costs Program Components Supporting Approval of Commercial TAVR Site Clinical Quality, Coordination Operations Staffing Exceptional outcomes for valve surgery; infrastructure for multidisciplinary decision making (e.g., valve case conferences) Branded valve/structural heart center; formal valve clinic screening model At least one physician with TAVR exposure; dedicated valve/TAVR nurse coordinator Transcatheter aortic valve replacement. Source: Babaliaros et al. "Comparison of Transfemoral Transcatheter Aortic Valve Replacement Performed In the Catheterization Laboratory (Minimalist Approach) Versus Hybrid Operating Room (Standard Approach)." JACC: Cardiovascular Interventions 7.8 (2014): Advisory Board Research and Analysis.

40 Market Size, Poor Financials Limit MitraClip Adoption
Service May Round Out Comprehensive Valve Clinic Offerings National Market Estimates for Major Structural Heart Procedures 2014 $35K Estimated Cost of MitraClip Device 2-3 Days Estimated MitraClip Patient LOS $14-$21K Baseline Medicare Payment Range1 $15K Maximum Technology Add-On Payment1 Key Drivers of MitraClip Adoption Program differentiator Utilizes TAVR program infrastructure Integrates HF, EP, and structural heart specialists Potential downstream revenue FY2016 rates. Source: Advisory Board Inpatient Market Estimator Tool. Advisory Board Research and Analysis.

41 Watchman Device Targets Significant AF1 Population
Device Offers Percutaneous Option to Seal Off Heart’s LAA2 Stroke Risk and Anticoagulant Use Among AF Patients in Commercial and Medicare Managed Care , n = 30,757 Treatment gap for stroke risk reduction therapies Low or Moderate Stroke Risk High Stroke Risk with Anticoagulant Use High Stroke Risk without Anticoagulant Use Portion of thrombi in non- valvular AF patients originating in the left atrial appendage (LAA) Considerations for Watchman Adoption Societal guidelines recommend substantial interventional experience prior to adoption Procedure reimbursed under MS- DRGs ; early adopters report challenging financial margins Atrial fibrillation. Left atrial appendage. Source: Lang, Kathleen, et al. “Anticoagulant use for the prevention of stroke in patients with atrial fibrillation: findings from a multi-payer analysis.” BMC Health Services Research. 14:329. Advisory Board Research and Analysis.

42 CardioMEMS Offers HF Remote Monitoring Platform
Device Sends Pulmonary Artery Data to Central Electronic System CardioMEMS in Brief CardioMEMS HF System designed for patients with New York Heart Association (NYHA) Class III HF who have been hospitalized within the past 12 months Device utilizes a permanent implantable PA sensor that does not require a battery, leads, or replaceable parts Sensor is implanted through a right heart catheterization procedure and measures a patient’s pulmonary artery (PA) pressure, which studies have shown can indicate worsening HF Data sent to electronic system that can be accessed daily System received FDA approval in May 2014 Heart Failure Hospitalization Rates per Patient-Year, CHAMPION Trial n = 550, $32B Annual cost to the U.S. health care system for heart failure patients Source: "Heart Failure Fact Sheet." Division for Heart Disease and Stroke Prevention. Centers for Disease Control and Prevention, 03 Dec Web. 05 Oct Abraham, William T. et al. “Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial.” Lancet. 387: Advisory Board Research and Analysis.

43 Fenestrated Stents Extend Endovascular Options
Niche Technology an Option for Advanced Aortic Centers Zenith Fenestrated AAA1 Endovascular Graft 24-Month Outcomes n= 23, 2009 Fenestrated Stents in Brief Fenestrated and branched AAA endografts are stents that have reinforced openings (fenestrations) or branches that allow physicians to attach arteries that lead to other organs Procedure is a viable option for patients who may have once been considered inoperable, such as those with complex aneurysms that are located throughout the entire length of the aorta Each fenestrated graft is customized to fit the precise anatomy of each aneurysm. Research suggests devices are both safe and effective in treating carefully selected patients, with low incidence of complications Aneurysm Shrinkage > 5 mm 70% 40% Percentage of patients ineligible for endovascular aneurysm repair with unfavorable anatomy of the proximal aortic neck 1) Abdominal aortic aneurysm. Source: Greenberg RK, et al., “Intermediate results of a United States multicenter trial of fenestrated endograft repair for juxtarenal abdominal aortic aneurysms,” J Vasc Surg, 2009, 50:730-7 Advisory Board Research and Analysis.

44 Physician and Infrastructure Needs for Key CV Growth Opportunities
Before Adoption Consider Infrastructure Needs Physician and Infrastructure Needs for Key CV Growth Opportunities Facilities Key Support Staff Physician Skill Set Key Specialist(s) TAVR Ideal: Hybrid OR or modified, sterile cath lab Ideal: Cross-trained or dedicated hybrid room RNs, techs, and valve coordinator (NP) Advanced interventional skills, including TAVR training requirements 2-5 proctored cases CV surgeon Interventional cardiologist (IC) Radial PCI Ideal: Cath lab Ideal: Cath lab RNs, techs with radial case training and experience Radial access experience, >50 cases preferable Interventional cardiologist EP Ablation Ideal: Dedicated EP lab, potentially hybrid OR for hybrid ablation Ideal: Dedicated EP RNs, techs, and AF coordinator RF ablation experience Additional cryoballoon training Cox-Maze experience EP CV surgeon (hybrid ablation) AAA and TAA Endografts Ideal: Hybrid OR Ideal: Cross-trained OR, cath staff or dedicated vascular team Endovascular training with open aneurysm repair experience Vascular surgery IC CV surgeons LEPAD Interventions Ideal: Dedicated vascular lab Ideal: Cath lab RN, techs Training in variety of access points Experience with numerous devices Vascular and CV surgeon IR Advanced HF Care, VADs Ideal: OR suite and dedicated HF clinic Ideal: Dedicated HF mid-levels, VAD coordinator HF training, experience with high acuity patients 10 VAD implants for DT certification HF specialist Source: Advisory Board Research and Analysis.

45 Additional Resources Growth Outlook Payment Updates
Reform & Payment Transformation Service Line Strategy Clinical Innovation Additional Resources

46 Enhancing CV Service Line Strategy
A Comprehensive Solution for Your CV Strategic Needs Service Line Strategy Advisor Cardiovascular Roundtable Service Line Assessment Current and future service line performance evaluation to pinpoint growth and development opportunities Unique insights based on market dynamics to drive fine-tuned recommendations National Meeting Series Two-day summits offering strategies and best practices to address contemporary challenges On-demand executive summary webconferences for ongoing support On-Demand Tools and Analytics Over two dozen online tools to analyze market opportunity, benchmark performance, expedite best practice implementation Technology and Service Business Plans Comprehensive market and financial analysis to determine investment decisions Concrete plans and prioritization accounting for institutional priorities, budget, and goals Best Practice Library Comprehensive library of over 500 best practices spanning all major CV domains (e.g., strategic planning, physician alignment, etc.) System Service Rationalization Strategic recommendations on clinical asset deployment and competitive strategy based on current system structure Tactical recommendations for service investments and distribution Facilitated Performance Improvement On-demand access to dedicated CV consultants “Ask Our Experts” model with immediate, customized response for your questions Facilitated networking with successful programs


Download ppt "Cardiovascular Market Trends"

Similar presentations


Ads by Google